← Open Payments lookup

FESTUS EBONKA: Open Payments

NPI 1932241007 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$475 in 20 payments from 10 companies in 2025. Trend: 2023 $275 · 2024 $589 · 2025 $475

Food & beverage: $475
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.5$122
Neurocrine BioSciences, Inc.3$86
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$50
AstraZeneca Pharmaceuticals LP2$47
Forte Bio-Pharma LLC2$46
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$29
Alkermes, Inc.1$28
PFIZER INC.1$27
ABBVIE INC.1$20
Lilly USA, LLC1$19

Products named: ABILIFY ASIMTUFII, INGREZZA, CAPLYTA, AIRSUPRA, PROLATE, XIFAXAN, REXULTI, ARISTADA.

Industry payments across NV — which companies pay providers there.